C olorectal cancer ranked first in incidence among Saudi males and third among Saudi females for the last several years according to Saudi Cancer Registry data. 1 A total of 1033 cases accounting for 10.4% of all newly diagnosed cases were reported in 2010. 1 The overall age standardized rate (ASR) was 9.6/100,000 with ASR of 9.9/100,000 for males and 9.2/100,000 for females. The median age at diagnosis was 60 years for males (range 2-100 years) and 55 years for females (range 13-100 years). 1 A committee of experts in the medical and surgical treatment of colorectal cancer was established under the supervision of the Saudi Oncology Society (SOS). The evidence adopted in these guidelines is rated at 3 levels: 1) Evidence level-1 (EL-1) (highest level) evidence from phase III randomized trials or meta-analyses; 2-EL-2 (intermediate-level) evidence from good phase II trials or phase III trials with limitations; and 3-EL-3 (low-level) from retrospective or observational data and/or expert opinion. This easy-to-follow grading system is convenient for the reader and allows accurate assessment of the applicability of the guideline in individual patients. 4 Ultimately, it was agreed that all colorectal cancer cases are preferably seen or discussed in a multidisciplinary form 1. Pre-treatment evaluation:
1. 
